ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
| 11/7/2024 9:30:22 AM | Chg. +0.200 | Volume | Bid3:18:53 PM | Ask3:18:53 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 102.900EUR | +0.19% | 1 Turnover: 102.900 |
101.750Bid Size: 59 | 102.700Ask Size: 59 | 20.43 bill.EUR | - | - |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,213.8000 | 1,207.3000 | 1,210.7000 | 1,224.7000 | 1,288.8000 | ||||||
| Intangible Assets | 827.1000 | 798.5000 | 740.7000 | 707.7000 | 603.5000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 5,345.7000 | ||||||
| Inventories | 936.4000 | 929.8000 | 995.3000 | 1,074.5000 | 1,169 | ||||||
| Accounts Receivable | 775.7000 | 838.8000 | 884.6000 | 936.6000 | 912.1000 | ||||||
| Cash and Cash Equivalents | 668.9000 | 768.3000 | 884.3000 | 1,080.6000 | 1,083.3000 | ||||||
| Current Assets | 3,009.7000 | 3,276.6000 | 3,708.7000 | 4,197.7000 | 4,289 | ||||||
| Total Assets | 7,999.9000 | 8,515.3000 | 9,012.4000 | 9,580.6000 | 9,634.7000 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 129.6000 | 143.3000 | 184.1000 | 146.3000 | 167.1000 | ||||||
| Long-term debt | - | - | - | - | 1,425.5000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 2,228.6000 | 3,000.5000 | 3,146.1000 | 3,280.5000 | 3,112.1000 | ||||||
| Share Capital | 2.5000 | 2.5000 | 2.6000 | 2.6000 | 2.7000 | ||||||
| Total Equity | 5,771.3000 | 5,507.2000 | 5,860.9000 | 6,297.3000 | 6,522.6000 | ||||||
| Minority Interests | 0.0000 | 7.6000 | 5.4000 | 2.8000 | 1.8000 | ||||||
| Total liabilities equity | 7,999.9000 | 8,515.3000 | 9,012.4000 | 9,580.6000 | 9,634.7000 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 4,220.2000 | 4,451.8000 | 4,471.7000 | 4,623.4000 | 4,673.3000 | ||||||
| Depreciation (total) | - | - | 96 | - | 375.8000 | ||||||
| Operating Result | 916.7000 | 1,024.1000 | 1,047.4000 | 1,035.6000 | 1,034.7000 | ||||||
| Interest Income | -56.5000 | -45.2000 | -57.3000 | -54.5000 | 11.9000 | ||||||
| Income Before Taxes | 860.2000 | 978.9000 | 990.1000 | 981.1000 | 943.9000 | ||||||
| Income Taxes | 263.3000 | 218.9000 | 237.2000 | 221.9000 | 224.9000 | ||||||
| Minority Interests Profit | 0.0000 | .8000 | 2.1000 | 1.8000 | -1.1000 | ||||||
| Net Income | 596.9000 | 760.8000 | 755 | 761 | 720.1000 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,193.5000 | 1,176.9000 | 1,151.9000 | 963.1000 | 1,052.8000 | ||||||
| Cash Flow from Investing Activities | -726.9000 | -624.4000 | -592.1000 | -282.5000 | -469.4000 | ||||||
| Cash Flow from Financing | -489.6000 | -455.8000 | -436.5000 | -467.3000 | -562.4000 | ||||||
| Decrease / Increase in Cash | -22.8000 | 99.4000 | 116 | 196.3000 | 2.7000 | ||||||
| Employees | 8,800 | 8,700 | 9,300 | 9,500 | 10,000 | ||||||
